Cataract Lens Pipeline
New cataract replacement lenses, and how far each one has got: in the lab, in a trial, or approved. Each fact links to its source.
Not medical advice. This page lists facts from public records. It does not tell you which lens to pick, and it does not tell you to wait for a new one. Ask your eye surgeon.
Last updated . 41 lenses and drugs.
How far each one has got
- Approved (US)
- 16
- The FDA approved it. A US surgeon can use it.
- Approved elsewhere
- 0
- On sale in Europe or other places. Not in the US.
- Pivotal trial
- 3
- The large trial that the FDA needs for approval.
- Early trial
- 22
- A small first test in people.
- Lab
- 0
- No test in people yet.
| Lens | Company | Stage | Type | Where you can get it | Status |
|---|---|---|---|---|---|
| Fixed focusMonofocal plus, EDOF (extended depth of focus), multifocal and trifocal lenses. The lens does not move. | |||||
| Alcon | Alcon | Approved (US) | EDOF | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric models.Regulator | |||||
| Alcon | Alcon | Approved (US) | Trifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens, also preloaded in the AutonoMe injector.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Approved (US) | Trifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens as a small optical change to Clareon PanOptix.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Approved (US) | EDOF | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric model.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Approved (US) | EDOF | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric models.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Lenstec | Lenstec | Approved (US) | Multifocal (bifocal) | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the new name, ClearView 3. The old name was SBL-3.Regulator FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Bausch & Lomb | Bausch & Lomb | Approved (US) | Multifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric model.Regulator | |||||
| Beaver-Visitec International (BVI) | Beaver-Visitec International (BVI) | Approved (US) | Trifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| AcuFocus | AcuFocus | Approved (US) | EDOF | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens for one eye only, to give monovision.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Rayner | Rayner | Approved (US) | Monofocal plus | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the toric model, RayOne EMV Toric.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Rayner | Rayner | Approved (US) | Multifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric model.Regulator | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Approved (US) | Monofocal plus | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric models.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Approved (US) | Multifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the toric model, TECNIS Odyssey Toric II.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Approved (US) | EDOF | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric models.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Approved (US) | Multifocal | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved the lens and its toric models.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Carl Zeiss Meditec | Carl Zeiss Meditec | Pivotal trial | Trifocal | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The US trial finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Bausch & Lomb | Bausch & Lomb | Pivotal trial | EDOF | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The US trial finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| SpyGlass Pharma | SpyGlass Pharma | Pivotal trial | Lens that holds a glaucoma drug | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The first of two US trials (Rhine) started.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Cristalens | Cristalens | Early trial | Multifocal | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial records. ClinicalTrials.gov now shows their status as unknown.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Carl Zeiss Meditec | Carl Zeiss Meditec | Early trial | EDOF | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in four European countries finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Early trial | — | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The second small trial in France finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Cutting Edge | Cutting Edge | Early trial | Trifocal | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in Czechia and Spain finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Teleon Surgical | Teleon Surgical | Early trial | Bifocal, for late macular degeneration | Unknown | Active |
Summary and trade-offs: not written yet. Latest: A trial was registered. It is planned to start in 2027.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Early trial | Trifocal | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial started in Australia, India and the Philippines.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Cutting Edge | Cutting Edge | Early trial | Monofocal plus | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in France started.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Cutting Edge | Cutting Edge | Early trial | Multifocal | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in France started.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Cutting Edge | Cutting Edge | Early trial | Monofocal plus | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. It still says active, after its planned end in April 2025.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Omega Ophthalmics | Omega Ophthalmics | Early trial | Lens holder (capsule) | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. ClinicalTrials.gov now shows its status as unknown.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| VisionCare | VisionCare | Early trial | Implantable telescope for late macular degeneration | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. It still says recruiting, after its planned end in December 2025.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Johnson & Johnson Surgical Vision | Johnson & Johnson Surgical Vision | Early trial | — | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in Australia and New Zealand finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Z Optics | Z Optics | Early trial | EDOF | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial started in Portugal, Spain and Switzerland.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Changes focusAccommodating lenses (they change shape like a young eye) and adjustable lenses (the doctor tunes them after surgery). | |||||
| RxSight | RxSight | Approved (US) | Adjustable | US now | Approved |
Summary and trade-offs: not written yet. Latest: The FDA approved LAL+, a model with a changed optical design.Regulator Trials
FDA approvalsSources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Early trial | Accommodating | Unknown | Discontinued |
Summary and trade-offs: not written yet. Latest: Alcon stopped the trial. The record gives the reason as a management decision.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Adaptilens | Adaptilens | Early trial | Accommodating | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial was registered. It has not started yet.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Alcon | Alcon | Early trial | Accommodating | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial record says the trial is active and takes no new people.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| LensGen | LensGen | Early trial | Accommodating | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. It still says the trial has not started.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| FSV6 | FSV6 | Early trial | Accommodating | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. ClinicalTrials.gov now shows its status as unknown.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Perfect Lens | Perfect Lens | Early trial | Laser adjustment of an implanted lens | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in Czechia finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| No surgeryDrugs that try to slow or clear a cataract.The FDA has not approved any drug or eye drop to treat a cataract. | |||||
| Nacuity Pharmaceuticals | Nacuity Pharmaceuticals | Early trial | Drug implant to slow cataract growth | Unknown | Active |
Summary and trade-offs: not written yet. Latest: The trial in Australia finished.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| University of Anbar | University of Anbar | Early trial | Eye drops | Unknown | Stalled |
Summary and trade-offs: not written yet. Latest: Last update of the trial record. It still says active, after its planned end in December 2024.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
| Ocusun Ophthalmic Pharmaceutical | Ocusun Ophthalmic Pharmaceutical | Early trial | Eye drug for cataract, used twice a day | Unknown | Active |
Summary and trade-offs: not written yet. Latest: A small pilot trial in the US started.Company claim Trials
Sources
Last reviewed 2026-11-21 | |||||
Status words
- Stalled:
- The trial record is out of date and the company is silent.
Words on this page
- IOL:
- Intraocular lens: the plastic lens a surgeon puts in the eye after the cloudy lens comes out.
- EDOF:
- Extended depth of focus.
- Toric:
- A toric lens fixes astigmatism.
- PMA:
- Premarket approval: the FDA path for these lenses.